<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00939471</url>
  </required_header>
  <id_info>
    <org_study_id>CPR01918</org_study_id>
    <nct_id>NCT00939471</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of Balloon Sinuplasty in Pediatric Sinusitis</brief_title>
  <acronym>INTACT</acronym>
  <official_title>Clinical Evaluation of Confirm the Safety and Efficacy of Balloon Sinuplasty Devices in the Treatment of Pediatric Sinusitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Acclarent</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Acclarent</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A non-randomized, multi-center, prospective, clinical study intended to evaluate the safety
      and efficacy of balloon sinuplasty devices in pediatric patients with longstanding sinusitis
      following failed medical management.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2007</start_date>
  <completion_date type="Actual">May 1, 2010</completion_date>
  <primary_completion_date type="Actual">July 1, 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety: Device-related Adverse Events During Balloon Dilation Through 12 Months</measure>
    <time_frame>12 months</time_frame>
    <description>Number of device-related adverse events from time of procedure through 12 months post-procedure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effectiveness: Change in Sinus Symptom Scores (SN-5)</measure>
    <time_frame>12 months</time_frame>
    <description>Change in sinus symptoms (mean reduction) for subjects less than 12 years of age evaluated using the SN-5 questionnaire at 52 weeks post-procedure compared to baseline. The maximum possible score for the SN-5 is seven and the minimum is one. A reduction in SN-5 score indicates improvement.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effectiveness: Change in Sinus Symptom Scores (SNOT-20)</measure>
    <time_frame>12 months</time_frame>
    <description>Change in sinus symptoms (mean reduction) for subjects 12 years of age or greater evaluated using the SNOT-20 questionnaire at 52 weeks post-procedure compared to baseline. The maximum possible score for the SNOT-20 is five and the minimum is zero. A reduction is SNOT-20 score indicates improvement.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Device Success: Ability to Access/Dilate Sinus Ostia</measure>
    <time_frame>12 months</time_frame>
    <description>Percentage of sinuses treated which were considered procedure success by the investigator relative to sinuses attempted.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effectiveness: Medication Thru 1 yr</measure>
    <time_frame>12 months</time_frame>
    <description>Data was summarized from the Global Patient Assessment Form. Each subject's last observation was used in order to account for any missing data or early termination of subjects. The results indicated represents the proportion of subjects (expressed as a percentage) who reported a decrease in medication usage at the time of their study discontinuation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effectiveness of Dilation/Measured by Post-op Interventions</measure>
    <time_frame>12 months</time_frame>
    <description>Effectiveness of balloon dilation as measured by the need for post-operative interventions other than revision sinus surgery. This endpoint evaluation includes irrigation and debridement. Number of post-operative interventions reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days Out of School During the 12 Months of Follow-up</measure>
    <time_frame>12 months</time_frame>
    <description>Quantitative assessment of days out of school during the 12 months of follow-up.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Revision Rate</measure>
    <time_frame>at 1 year</time_frame>
    <description>The number of subjects requiring revisions out of 33 subjects treated.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>Chronic Sinusitis</condition>
  <arm_group>
    <arm_group_label>Relieva™ Balloon Sinuplasty™ System</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Balloon Dilation of sinus ostium</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Relieva™ Balloon Sinuplasty™ System</intervention_name>
    <description>Balloon dilation will be performed using endoscopic equipment with video documentation capability.</description>
    <arm_group_label>Relieva™ Balloon Sinuplasty™ System</arm_group_label>
    <other_name>Relieva</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age &gt; 2 and &lt; 18 years

          2. Both male and female patients eligible

          3. Planned surgical intervention (i.e. endoscopic sinus surgery, adenoidectomy, sinus
             irrigation for obtaining a culture) recommended by PI, consented to by patient's legal
             guardian)

          4. Longstanding sinusitis: &gt;3 mo symptoms OR 6 episodes/yr AND failed 2 courses
             antibiotics followed by positive CT scan

        Exclusion Criteria:

          1. Extensive previous sinonasal surgery in target ostia

          2. Cystic fibrosis

          3. Extensive sinonasal osteoneogenesis

          4. Sinonasal tumors or obstructive lesions

          5. History of facial trauma that distorts sinus anatomy and precludes access to the sinus
             ostium

          6. Ciliary dysfunction

          7. For female patients of childbearing age: the patient is either pregnant or lactating
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hassan Ramadan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>West Virginia University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>West Virginia University</name>
      <address>
        <city>Morgantown</city>
        <state>West Virginia</state>
        <zip>26506</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 14, 2009</study_first_submitted>
  <study_first_submitted_qc>July 14, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 15, 2009</study_first_posted>
  <results_first_submitted>July 20, 2011</results_first_submitted>
  <results_first_submitted_qc>July 10, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 17, 2012</results_first_posted>
  <last_update_submitted>August 4, 2017</last_update_submitted>
  <last_update_submitted_qc>August 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sinusitis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Balloon Device</title>
          <description>Balloon catheter dilation of sinus ostia</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="44"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Balloon Device</title>
          <description>Balloon catheter dilation of sinus ostia</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="44"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8.14" spread="3.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Safety: Device-related Adverse Events During Balloon Dilation Through 12 Months</title>
        <description>Number of device-related adverse events from time of procedure through 12 months post-procedure.</description>
        <time_frame>12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Balloon Sinuplasty Treatment</title>
            <description>Balloon catheter dilation of sinus ostia</description>
          </group>
        </group_list>
        <measure>
          <title>Safety: Device-related Adverse Events During Balloon Dilation Through 12 Months</title>
          <description>Number of device-related adverse events from time of procedure through 12 months post-procedure.</description>
          <units>number of events</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Effectiveness: Change in Sinus Symptom Scores (SN-5)</title>
        <description>Change in sinus symptoms (mean reduction) for subjects less than 12 years of age evaluated using the SN-5 questionnaire at 52 weeks post-procedure compared to baseline. The maximum possible score for the SN-5 is seven and the minimum is one. A reduction in SN-5 score indicates improvement.</description>
        <time_frame>12 months</time_frame>
        <population>Data calculated for matched pairs (subjects with baseline and 12 months follow-up scores).</population>
        <group_list>
          <group group_id="O1">
            <title>Balloon Sinuplasty Treatment</title>
            <description>Balloon catheter dilation of sinus ostia</description>
          </group>
        </group_list>
        <measure>
          <title>Effectiveness: Change in Sinus Symptom Scores (SN-5)</title>
          <description>Change in sinus symptoms (mean reduction) for subjects less than 12 years of age evaluated using the SN-5 questionnaire at 52 weeks post-procedure compared to baseline. The maximum possible score for the SN-5 is seven and the minimum is one. A reduction in SN-5 score indicates improvement.</description>
          <population>Data calculated for matched pairs (subjects with baseline and 12 months follow-up scores).</population>
          <units>change in SN-5 score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.00" spread="1.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Device Success: Ability to Access/Dilate Sinus Ostia</title>
        <description>Percentage of sinuses treated which were considered procedure success by the investigator relative to sinuses attempted.</description>
        <time_frame>12 months</time_frame>
        <population>intent to treat analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Balloon Sinuplasty Treatment</title>
            <description>Balloon catheter dilation of sinus ostia</description>
          </group>
        </group_list>
        <measure>
          <title>Device Success: Ability to Access/Dilate Sinus Ostia</title>
          <description>Percentage of sinuses treated which were considered procedure success by the investigator relative to sinuses attempted.</description>
          <population>intent to treat analysis</population>
          <units>percentage of sinuses successful</units>
          <param>Number</param>
          <units_analyzed>sinuses</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>sinuses</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="88"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Effectiveness: Medication Thru 1 yr</title>
        <description>Data was summarized from the Global Patient Assessment Form. Each subject's last observation was used in order to account for any missing data or early termination of subjects. The results indicated represents the proportion of subjects (expressed as a percentage) who reported a decrease in medication usage at the time of their study discontinuation.</description>
        <time_frame>12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Balloon Sinuplasty Treatment</title>
            <description>Balloon catheter dilation of sinus ostia</description>
          </group>
        </group_list>
        <measure>
          <title>Effectiveness: Medication Thru 1 yr</title>
          <description>Data was summarized from the Global Patient Assessment Form. Each subject's last observation was used in order to account for any missing data or early termination of subjects. The results indicated represents the proportion of subjects (expressed as a percentage) who reported a decrease in medication usage at the time of their study discontinuation.</description>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Effectiveness of Dilation/Measured by Post-op Interventions</title>
        <description>Effectiveness of balloon dilation as measured by the need for post-operative interventions other than revision sinus surgery. This endpoint evaluation includes irrigation and debridement. Number of post-operative interventions reported.</description>
        <time_frame>12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Balloon Sinuplasty Treatment</title>
            <description>Balloon catheter dilation of sinus ostia</description>
          </group>
        </group_list>
        <measure>
          <title>Effectiveness of Dilation/Measured by Post-op Interventions</title>
          <description>Effectiveness of balloon dilation as measured by the need for post-operative interventions other than revision sinus surgery. This endpoint evaluation includes irrigation and debridement. Number of post-operative interventions reported.</description>
          <units>number of interventions</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Days Out of School During the 12 Months of Follow-up</title>
        <description>Quantitative assessment of days out of school during the 12 months of follow-up.</description>
        <time_frame>12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Balloon Sinuplasty Treatment</title>
            <description>Balloon catheter dilation of sinus ostia</description>
          </group>
        </group_list>
        <measure>
          <title>Days Out of School During the 12 Months of Follow-up</title>
          <description>Quantitative assessment of days out of school during the 12 months of follow-up.</description>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.75" spread="7.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Revision Rate</title>
        <description>The number of subjects requiring revisions out of 33 subjects treated.</description>
        <time_frame>at 1 year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Balloon Sinuplasty Treatment</title>
            <description>Balloon catheter dilation of sinus ostia</description>
          </group>
        </group_list>
        <measure>
          <title>Revision Rate</title>
          <description>The number of subjects requiring revisions out of 33 subjects treated.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Effectiveness: Change in Sinus Symptom Scores (SNOT-20)</title>
        <description>Change in sinus symptoms (mean reduction) for subjects 12 years of age or greater evaluated using the SNOT-20 questionnaire at 52 weeks post-procedure compared to baseline. The maximum possible score for the SNOT-20 is five and the minimum is zero. A reduction is SNOT-20 score indicates improvement.</description>
        <time_frame>12 months</time_frame>
        <population>Data calculated for matched pairs (subjects with baseline and 12 months follow-up scores).</population>
        <group_list>
          <group group_id="O1">
            <title>Balloon Sinuplasty Treatment</title>
            <description>Balloon catheter dilation of sinus ostia</description>
          </group>
        </group_list>
        <measure>
          <title>Effectiveness: Change in Sinus Symptom Scores (SNOT-20)</title>
          <description>Change in sinus symptoms (mean reduction) for subjects 12 years of age or greater evaluated using the SNOT-20 questionnaire at 52 weeks post-procedure compared to baseline. The maximum possible score for the SNOT-20 is five and the minimum is zero. A reduction is SNOT-20 score indicates improvement.</description>
          <population>Data calculated for matched pairs (subjects with baseline and 12 months follow-up scores).</population>
          <units>change in SNOT-20 score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.95" spread="0.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Balloon Device</title>
          <description>Balloon catheter dilation of sinus ostia</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="44"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="44"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Scientific Publications Reporting results initiated only by SPONSOR. Sites may not publish single center results before aggregate results. Drafts of abstracts, etc. must be submitted to SPONSOR for review at least sixty (60) days prior to submission for publication. Investigator(s) shall delay submission for up to 90 days to permit patent application filing or shall redact paper to remove language detrimental to SPONSOR’s intellectual property interests.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Laura England, Manager-Clinical</name_or_title>
      <organization>Acclarent, Inc.</organization>
      <phone>650-687-4466</phone>
      <email>lenglan1@its.jnj.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

